CaP MEDs
The computed 12-month bankruptcy probability of CaP MEDs is 1.5% (low). The company has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 17 yrs |
| Locations | 2 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-10-2021 | volledig | 29-01-2023 | 2023-00009501 |
| 31-10-2019 | volledig | 26-08-2020 | 2020-44400262 |
| 31-10-2017 | volledig | 30-08-2018 | 2018-56600144 |
| 31-10-2016 | volledig | 24-05-2018 | 2018-14300405 |
| 31-10-2015 | volledig | 07-07-2018 | 2018-31300110 |
| 31-10-2014 | volledig | 27-07-2017 | 2017-37300161 |
| 31-10-2013 | volledig | 07-07-2018 | 2018-31200336 |
| 31-10-2012 | volledig | 07-07-2018 | 2018-31200335 |
| 31-10-2011 | volledig | 13-07-2018 | 2018-32600190 |
| 31-10-2010 | volledig | 30-07-2018 | 2018-42700274 |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 09-10-2008 |
| Status | Active |
| Postal code | 5650 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52031B0068/00V000 | Wallonia | 5,208 m² | 1 · 157 m² | 9.1 m · 2 fl. |
| 93088A0196/00Y000 | Wallonia | 276 m² | 1 · 144 m² | - |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
09-11-2022 Change in the board of directors
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "directeur",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "J. JORDENS",
"address": "1180 Bruxelles, avenue Kersbeek 308",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e a conf\u00E9r\u00E9 tous pouvoirs aux soci\u00E9t\u00E9s \u00AB J. JORDENS \u00BB et \u00AB KREANOVE \u00BB, dont le si\u00E8ge est situ\u00E9 \u00E0 1180 Bruxelles, avenue Kersbeek 308, repr\u00E9sent\u00E9es par Monsieur SOLAU Serge, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer la modifi",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "substantive_delegation",
"role": "directeur",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "KREANOVE",
"address": "1180 Bruxelles, avenue Kersbeek 308",
"country": "BE",
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e a conf\u00E9r\u00E9 tous pouvoirs aux soci\u00E9t\u00E9s \u00AB J. JORDENS \u00BB et \u00AB KREANOVE \u00BB, dont le si\u00E8ge est situ\u00E9 \u00E0 1180 Bruxelles, avenue Kersbeek 308, repr\u00E9sent\u00E9es par Monsieur SOLAU Serge, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer la modifi",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Catherine HATERT",
"firm_city": null,
"firm_name": null,
"office_city": "Saint-Josse-ten-Noode",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2022-11-09",
"filing_date": "2022-11-07",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2022-10-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0806.985.857",
"name_full": "CaP MEDs",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Catherine HATERT",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"statuts coordonn\u00E9s",
"procurations",
"dispenses"
],
"corrected_publication_numac": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | CaP MEDs |